KNTE Annual Working Capital
$146.18 M
-$67.49 M-31.59%
01 December 2023
Summary:
As of January 20, 2025, KNTE annual working capital is $146.18 million, with the most recent change of -$67.49 million (-31.59%) on December 1, 2023. During the last 3 years, it has fallen by -$246.72 million (-62.79%).KNTE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNTE Quarterly Working Capital
$146.18 M
-$8.35 M-5.40%
01 December 2023
Summary:
As of January 20, 2025, KNTE quarterly working capital is $146.18 million, with the most recent change of -$8.35 million (-5.40%) on December 1, 2023. Over the past year, it has dropped by -$8.35 million (-5.40%).KNTE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNTE Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.6% | -5.4% |
| 3 y3 years | -62.8% | -5.4% |
| 5 y5 years | +1820.9% | -5.4% |
KNTE Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -62.8% | -62.8% |
Kinnate Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $146.18 M(-31.6%) | $146.18 M(-5.4%) |
| Sept 2023 | - | $154.53 M(-10.6%) |
| June 2023 | - | $172.83 M(-7.6%) |
| Mar 2023 | - | $187.13 M(-12.4%) |
| Dec 2022 | $213.67 M(-13.2%) | $213.67 M(-13.1%) |
| Sept 2022 | - | $245.83 M(-3.8%) |
| June 2022 | - | $255.67 M(-2.2%) |
| Mar 2022 | - | $261.54 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $246.30 M(-37.3%) | $246.30 M(-1.6%) |
| Sept 2021 | - | $250.41 M(-0.0%) |
| June 2021 | - | $250.46 M(+2.9%) |
| Mar 2021 | - | $243.38 M(-38.1%) |
| Dec 2020 | $392.90 M(+420.4%) | $392.90 M(+160.6%) |
| Sept 2020 | - | $150.78 M(+99.7%) |
| Dec 2019 | $75.51 M(+892.2%) | $75.51 M |
| Dec 2018 | $7.61 M | - |
FAQ
- What is Kinnate Biopharma annual working capital?
- What is the all time high annual working capital for Kinnate Biopharma?
- What is Kinnate Biopharma annual working capital year-on-year change?
- What is Kinnate Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Kinnate Biopharma?
- What is Kinnate Biopharma quarterly working capital year-on-year change?
What is Kinnate Biopharma annual working capital?
The current annual working capital of KNTE is $146.18 M
What is the all time high annual working capital for Kinnate Biopharma?
Kinnate Biopharma all-time high annual working capital is $392.90 M
What is Kinnate Biopharma annual working capital year-on-year change?
Over the past year, KNTE annual working capital has changed by -$67.49 M (-31.59%)
What is Kinnate Biopharma quarterly working capital?
The current quarterly working capital of KNTE is $146.18 M
What is the all time high quarterly working capital for Kinnate Biopharma?
Kinnate Biopharma all-time high quarterly working capital is $392.90 M
What is Kinnate Biopharma quarterly working capital year-on-year change?
Over the past year, KNTE quarterly working capital has changed by -$8.35 M (-5.40%)